Estradiol's Role in Cardiovascular and Systemic Effects

Cardiovascular Effects

Estradiol has more pronounced effects on the renin-angiotensin-aldosterone system (RAAS), increasing angiotensinogen production more significantly than other estrogens, particularly in postmenopausal women 1
Estradiol demonstrates stronger cardiovascular effects, increasing stroke volume, heart rate, and contractility while reducing peripheral vascular resistance in postmenopausal women 2, 1

In women with chronic kidney disease, estradiol serum concentrations may be over 20% greater than in women with normal renal function, suggesting these patients should receive 50-70% lower doses to achieve equivalent concentrations, as recommended by the American Journal of Kidney Diseases 2

For women using aromatase inhibitors after breast cancer, estriol-containing preparations (derived from estrone) may be preferable over estradiol-containing ones since estriol cannot be converted back to estradiol, according to Praxis Medical Insights 1, 3
Vaginal estradiol may increase circulating estradiol levels in aromatase inhibitor users within 2 weeks, potentially reducing the efficacy of these cancer treatments, as noted by Praxis Medical Insights 3